Literature DB >> 6289860

The effects of fenfluramine on in vitro platelet aggregation.

M A Barradas, A M Mikhailidis, D P Mikhailidis, P Dandona.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6289860      PMCID: PMC1427642          DOI: 10.1111/j.1365-2125.1982.tb02013.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  7 in total

1.  Novel alpha2-adrenoreceptors primarily responsible for inducing human platelet aggregation.

Authors:  J A Grant; M C Scrutton
Journal:  Nature       Date:  1979-02-22       Impact factor: 49.962

2.  Fenfluramine overdosage.

Authors:  M R Fleisher; D B Campbell
Journal:  Lancet       Date:  1969-12-13       Impact factor: 79.321

3.  Fenfluramine overdosage.

Authors:  D B Campbell; B W Moore
Journal:  Lancet       Date:  1969-12-13       Impact factor: 79.321

4.  Fenfluramine overdosage.

Authors:  R G Gold; H E Gordon; R W Da Costa; I B Porteous; K J Kimber
Journal:  Lancet       Date:  1969-12-13       Impact factor: 79.321

5.  Protection of prostacyclin-like activity in human plasma-a non-enzymatic mechanism?

Authors:  D P Mikhailidis; A M Mikhailidis; M L Woollard; P Dandona
Journal:  Clin Sci (Lond)       Date:  1982-02       Impact factor: 6.124

Review 6.  Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1975       Impact factor: 9.546

7.  Possible dangers of anaesthesia in patients receiving fenfluramine. Results of animal studies following a case of human cardiac arrest.

Authors:  J A Bennett; R J Eltringham
Journal:  Anaesthesia       Date:  1977-01       Impact factor: 6.955

  7 in total
  3 in total

1.  The effect of fenfluramine on collagen-induced platelet aggregation in vitro.

Authors:  M A Barradas; D P Mikhailidis; P Dandona
Journal:  Br J Clin Pharmacol       Date:  1983-10       Impact factor: 4.335

2.  Fibrinogen mediated activation of platelet aggregation and thromboxane A2 release: pathological implications in vascular disease.

Authors:  D P Mikhailidis; M A Barradas; A Maris; J Y Jeremy; P Dandona
Journal:  J Clin Pathol       Date:  1985-10       Impact factor: 3.411

3.  Comparison of the effect of a conventional heparin and a low molecular weight heparinoid on platelet function.

Authors:  D P Mikhailidis; M A Barradas; A M Mikhailidis; H Magnani; P Dandona
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.